Ronald Asbury Andrews - Dec 1, 2022 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Former CEO, Director
Signature
/s/ Ronald Andrews
Stock symbol
OCX
Transactions as of
Dec 1, 2022
Transactions value $
$0
Form type
4
Date filed
12/9/2022, 07:23 PM
Previous filing
Aug 18, 2022
Next filing
Jan 10, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Options Exercise $0 +250K +75.03% $0.00 583K Dec 1, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -20K -100% $0.00* 0 Dec 1, 2022 Common Stock 20K $2.10 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -45K -100% $0.00* 0 Dec 1, 2022 Common Stock 45K $2.40 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -950K -100% $0.00* 0 Dec 1, 2022 Common Stock 950K $2.51 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -50K -100% $0.00* 0 Dec 1, 2022 Common Stock 50K $1.68 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -500K -100% $0.00* 0 Dec 1, 2022 Common Stock 500K $5.34 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -300K -100% $0.00* 0 Dec 1, 2022 Common Stock 300K $1.15 Direct F1
transaction OCX Option to Purchase Common Stock Disposed to Issuer $0 -93.8K -25% $0.00 281K Dec 1, 2022 Common Stock 93.8K $1.15 Direct F1
transaction OCX Restricted Stock Units Disposed to Issuer $0 -35K -100% $0.00* 0 Dec 1, 2022 Common Stock 35K $0.00 Direct F2
transaction OCX Restricted Stock Units Disposed to Issuer $0 -250K -50% $0.00 250K Dec 1, 2022 Common Stock 250K $0.00 Direct F2
transaction OCX Restricted Stock Units Options Exercise $0 -250K -100% $0.00* 0 Dec 1, 2022 Common Stock 250K $0.00 Direct F2
transaction OCX Option to Purchase Common Stock Award $0 +50K $0.00 50K Dec 7, 2022 Common Stock 50K $0.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining options immediately vested and became exercisable as of December 1, 2022.
F2 The restricted stock units were forfeited by mutual agreement of the Reporting Person and the Issuer in connection with a severance agreement entered into as a result of the Reporting Person's resignation as an officer and director of the Issuer on December 1, 2022. Any remaining restricted stock units immediately vested on December 1, 2022.
F3 Options vest (and thereby become exercisable) as follows: (i) one-third on December 31, 2022, (ii) one-third on January 31, 2023, and (iii) one-third on February 28, 2023 (each such date, a "Vesting Date"), in each case, subject to the Reporting Person's continuous service as a consultant on each applicable Vesting Date.